BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 918483)

  • 1. [Single-stage prothrombin time: standardization of reagents; Brazilian thromboplastin reference].
    Guerra CC; Borges DR; Nahas L; Rosenfeld LG
    Rev Paul Med; 1977; 89(1-2):21-3. PubMed ID: 918483
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
    Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
    Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin time standardization report of the expert panel on oral anticoagulant control: a minority opinion.
    Miale JB
    Thromb Haemost; 1979 Dec; 42(4):1132-4. PubMed ID: 542926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 5. [Standardization of the thromboplastin time determination].
    Dati F
    Z Med Lab Diagn; 1990; 31(4):211-24. PubMed ID: 2382469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of several commercial thromboplastins to non-carboxylated clotting factors II and X (author's transl)].
    Averdunk R; Grüner J
    J Clin Chem Clin Biochem; 1981 Feb; 19(2):89-97. PubMed ID: 7217898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
    Biggs R; Denson KW
    Thromb Diath Haemorrh Suppl; 1967; 26():445-50. PubMed ID: 6064876
    [No Abstract]   [Full Text] [Related]  

  • 8. A liquid thromboplastin reagent for the determination of PT.
    Butler J; Torres J; Callahan J
    Am Clin Lab; 1994 Mar; 13(3):16-7. PubMed ID: 10147376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methodological aspects of the photometric determination of prothrombin time using chromogenic substrates].
    Dati F; Kolde HJ; Heimburger N; Keller F
    J Clin Chem Clin Biochem; 1986 Nov; 24(11):877-88. PubMed ID: 3806016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the quality of prothrombin time technique in the Basque Country].
    Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
    Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
    Denson KW
    Thromb Diath Haemorrh Suppl; 1968; 35():197-208. PubMed ID: 5761492
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of variables affecting PTs/INRs.
    McGlasson DL
    Clin Lab Sci; 1999; 12(6):353-8. PubMed ID: 10724633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of anticoagulant therapy by using soluble thromboplastin].
    Gaĭda AV; Monastyrskiĭ VA; Magerovskiĭ IuV; Torik ZhN
    Lab Delo; 1989; (10):20-3. PubMed ID: 2481064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Discussion on the stardardization of thromboplastin time].
    Lasch HG; Heene D
    Internist (Berl); 1969 Aug; 10(8):Suppl:39-40. PubMed ID: 4904087
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of some instruments for prothrombin time testing on the International Sensitivity Index (ISI) of two rabbit tissue thromboplastin reagents.
    Poggio M; van den Besselaar AM; van der Velde EA; Bertina RM
    Thromb Haemost; 1989 Nov; 62(3):868-74. PubMed ID: 2595661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the INR system for patients with liver impairment.
    Denson KW; Reed SV; Haddon ME
    Thromb Haemost; 1995 Jan; 73(1):162. PubMed ID: 7740488
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of heparinase to eliminate heparin inhibition in routine coagulation assays.
    Hutt ED; Kingdon HS
    J Lab Clin Med; 1972 Jun; 79(6):1027-34. PubMed ID: 5025456
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboplastin as a reagent.
    Quick AJ
    Thromb Diath Haemorrh; 1970 Jun; 23(3):585-92. PubMed ID: 4194160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.